IP
PFE icon

Indivisible Partners’s Pfizer PFE Stock Holding History

Indivisible Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
+46,671
New +$1.22M 0.06% 216

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Indivisible Partners's PFE Position: Q2 2026 in Review

Indivisible Partners opened a new position in Pfizer (PFE) in Q2 2026: 46,671 shares worth $1.12M. The stake represents 0.06% of the portfolio and ranks #216 among its holdings.

2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Indivisible Partners held 46,671 shares of Pfizer worth $1.12M as of Q2 2026.
  • Pfizer was a new Indivisible Partners position in Q2 2026.
  • Pfizer made up 0.06% of Indivisible Partners's portfolio in Q2 2026, its #216 holding.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Indivisible Partners's 13F filing for Q2 2026, filed 4 Aug 2026.